Medicalgorithmics

Medicalgorithmics Cash Ratio

Cash Ratio of Medicalgorithmics (MDG.WA) as of Nov 22, 2026.

Cash Ratio

-

Last updated:

Cash Ratio of Medicalgorithmics is 2026 - . Cash Ratio of Medicalgorithmics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics SA develops and manufactures the PocketECG system for remote heart arrhythmia diagnosis and monitoring, used in clinical drug trials for cardiac safety. The company provides IT and biotechnology services, scientific R&D in natural sciences, and works on tele-rehabilitation cardiology devices, hospital task optimization software, and remote ECG description systems. Its products serve healthcare providers, pharmaceutical companies conducting cardiac safety trials, and medical institutions requiring remote cardiac monitoring solutions. The firm operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC, offering diagnostic technology and related services to global healthcare markets. Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

On Eulerpool you can find the complete historical development of Cash Ratio Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

The Cash Ratio is the most conservative liquidity metric, comparing only cash and equivalents to current liabilities.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Ratio's Medicalgorithmics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Medicalgorithmics

All Key Metrics — Medicalgorithmics